Xavier Duportet

Founder and CEO, Eligo Bioscience
Creating programmable biological agents to eradicate bacteria by hacking their genome

Named by MIT Technology Review as one of the top innovators under 35, Xavier is  enlisting the trillions of bacteria that make up the human microbiome to play an essential new role. He is working on substituting the "weapons of mass destruction” that can be current antibiotics, for “snipers” that work much more precisely, using code sequence specific antimicrobials. Leveraging the CRISPR code cutting technique,  the PhD in Synthetic Biology from INRIA, France’s leading computer science institute, and the Massachusetts Institute of Technology in Boston is using the cutting-edge tools of synthetic biology not only to create new genetic cosmetics, but also to find novel ways to the ticking time-bomb of ever growing antimicrobial resistance.